Smart Doctor's assistant aims to stop second strokes
NCT ID NCT07143149
Summary
This study is testing a new computer-based support system designed to help doctors manage cholesterol levels in patients who have had a stroke or mini-stroke (TIA). It will involve 4000 patients in China who are already taking a specific cholesterol-lowering drug called Evolocumab. The main goal is to see if this smart system helps more patients reach and maintain a healthy cholesterol target over one year, which could lower their risk of having another stroke.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.